Form 4 holding
PRESIDENT, TBIL
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 110,319
- Estimated value
- $1,135,183
- Report date
- 18 Feb 2022
- Price
- $10.29
- Ownership
- Direct
Ann Brady - PRESIDENT, TBIL at Theravance Biopharma, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- President, Tbil
- Issuer Symbol
- TBPH on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Ann Brady since 23 May 2025
Holdings reported by Ann Brady for Theravance Biopharma, Inc.
Transactions reported by Ann Brady for Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.